Funakoshi Yu, Ito Kenta, Morino Saeko, Kinoshita Kazue, Morikawa Yoshihiko, Kono Tatsuo, Doan Yen Hai, Shimizu Hiroyuki, Hanaoka Nozomu, Konagaya Masami, Fujimoto Tsuguto, Suzuki Ai, Chiba Takashi, Akiba Tetsuya, Tomaru Yasuhiro, Watanabe Ken, Shimizu Norio, Horikoshi Yuho
Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
Pediatr Int. 2019 Aug;61(8):768-776. doi: 10.1111/ped.13903. Epub 2019 Aug 22.
Outbreaks of enterovirus D68 (EV-D68) respiratory infections in children were reported globally in 2014. In Japan, there was an EV-D68 outbreak in the autumn of 2015 (September-October). The aim of this study was to compare EV-D68-specific polymerase chain reaction (PCR)-positive and EV-D68-specific PCR-negative patients.
Pediatric patients admitted for any respiratory symptoms between September and October 2015 were enrolled. Nasopharyngeal swabs were tested for multiplex respiratory virus PCR and EV-D68-specific reverse transcription-PCR. EV-D68-specific PCR-positive and -negative patients were compared regarding demographic data and clinical information.
A nasopharyngeal swab was obtained from 76 of 165 patients admitted with respiratory symptoms during the study period. EV-D68 was detected in 40 samples (52.6%). Median age in the EV-D68-specific PCR-positive and -negative groups was 3.0 years (IQR, 5.5 years) and 3.0 years (IQR, 4.0 years), respectively. The rates of coinfection in the two groups were 32.5% and 47.2%, respectively. There was no significant difference in the history of asthma or recurrent wheezing, length of hospitalization, or pediatric intensive care unit admission rate between the groups. The median days between symptom onset and admission was significantly lower for the EV-D68-positive group (3.0 days vs 5.0 days, P = 0.001). EV-D68 was identified as clade B on phylogenetic analysis. No cases of acute flaccid myelitis were encountered.
More than half of the samples from the children admitted with respiratory symptoms were positive for EV-D68-specific PCR during the outbreak. Asthma history was not associated with the risk of developing severe respiratory infection.
2014年全球报告了儿童肠道病毒D68(EV-D68)呼吸道感染疫情。在日本,2015年秋季(9月至10月)发生了EV-D68疫情。本研究的目的是比较EV-D68特异性聚合酶链反应(PCR)阳性和EV-D68特异性PCR阴性患者。
纳入2015年9月至10月因任何呼吸道症状入院的儿科患者。对鼻咽拭子进行多重呼吸道病毒PCR和EV-D68特异性逆转录PCR检测。比较EV-D68特异性PCR阳性和阴性患者的人口统计学数据和临床信息。
在研究期间,165例因呼吸道症状入院的患者中有76例采集了鼻咽拭子。40份样本(52.6%)检测到EV-D68。EV-D68特异性PCR阳性组和阴性组的中位年龄分别为3.0岁(四分位间距,5.5岁)和3.0岁(四分位间距,4.0岁)。两组的合并感染率分别为32.5%和47.2%。两组之间哮喘或反复喘息病史、住院时间或儿科重症监护病房入住率无显著差异。EV-D68阳性组症状出现至入院的中位天数显著更低(3.0天对5.0天,P = 0.001)。系统发育分析显示EV-D68被鉴定为B分支。未遇到急性弛缓性脊髓炎病例。
疫情期间,因呼吸道症状入院儿童的样本中,超过一半的EV-D68特异性PCR检测呈阳性。哮喘病史与发生严重呼吸道感染的风险无关。